Trial intelligence / Profile preview

Oral Versus Intramuscular Cobalamin to Treat Cobalamin Deficiency in Older Adults (OB12)

2010-024129-20Phase 4Completed

Sponsor
CAIBER
Start
Nov 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of cyanocobalamin in vitamin B12 deficiency (2 arms), sponsored by CAIBER. Primary endpoints: Normalization of plasma vitamin B12 levels at week 8, Normalization of plasma vitamin B12 levels at week 26 and 1 more. Started Nov 2011; status: completed.

02

Drugs

cyanocobalamin
03

Conditions

vitamin B12 deficiency

Beyond the preview

Go deeper on 2010-024129-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-024129-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call